Residual spasticity

Oral - For the control of clinical spasticity resulting from upper motor neuron disorders such as spinal cord injury, stroke, cerebral palsy, or multiple sclerosis. It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. 

These functional improvements, however, may not occur in all types of spasticity. Patients with severe spasticity of spinal origin, for example, may not experience improvements in mobility or decreased disability.103 If these patients do not have adequate voluntary motor function there is simply not enough residual motor ability to perform functional tasks after spasticity is reduced. Nonetheless, these patients may still benefit from intrathecal baclofen because of decreased rigidity and pain, which can result in improved self-care and the ability to perform daily living activities.37,74,76... 

---